AstraZeneca: D3569C00011

The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in non-diabetes with moderate proteinuria and hypercholesterolaemia.

© Copyright - Southeastern Clinical Research Institute | Website developed and maintained by Here Molly Girl